![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Five years of Treatment with Tenofovir DF for Chronic Hepatitis B Infection in Asian Patients is Associated with Sustained Viral Suppression and Significant Regression of Histological Fibrosis and Cirrhosis
|
|
|
Reported by Jules Levin
AASLD Nov 5-8 2011 SF
E.J. Gane1, P. Marcellin2, W. Sievert3, H.N. Trinh4, M.L. Shiffman5, M.K. Washington6, C.N. Barnes7, J.D. Bornstein7, J.F. Flaherty7, E.J. Heathcote8
1Auckland City Hospital, Auckland, New Zealand , 2Hopital Beaujon, Clichy, France, 3Monash University, Melbourne, VIC, Australia, , 4San Jose Gastroenterology, San Jose, CA, 5Virginia Commonwealth University Medical Center, Richmond, VA, 6Vanderbilt University, Nashville, TN, 7Gilead Sciences Inc., Foster City, CA, 8University of Toronto, Toronto, ON, Canada
![AASLD1.gif](../images/111411/111411-1/AASLD1.gif)
![AASLD2.gif](../images/111411/111411-1/AASLD2.gif)
![AASLD3.gif](../images/111411/111411-1/AASLD3.gif)
![AASLD4.gif](../images/111411/111411-1/AASLD4.gif)
![AASLD5.gif](../images/111411/111411-1/AASLD5.gif)
![AASLD6.gif](../images/111411/111411-1/AASLD6.gif)
![AASLD7.gif](../images/111411/111411-1/AASLD7.gif)
![AASLD8.gif](../images/111411/111411-1/AASLD8.gif)
![AASLD9.gif](../images/111411/111411-1/AASLD9.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|